Kelly Marie Morse Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 20 Toria Heights Rd, Oxford, MA 01540 Phone: 508-887-0223 |
Ms. Elizabeth A Danforth, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 14 Ballard St, Oxford, MA 01540 Phone: 508-340-1206 |
Ms. Heather Lin Rosenquist, B.S. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 130 Charlton St, # 3, Oxford, MA 01540 Phone: 508-341-7040 |
Margaret Ann Sali, LICSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 316 Main St, Oxford, MA 01540 Phone: 508-987-3771 Fax: 508-987-3441 |
News Archive
Optimer Pharmaceuticals, Inc. announced that data from the fidaxomicin Phase 3 clinical studies will be presented at the 20th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Vienna, Austria.
Orexigen Therapeutics, Inc. today announced that its 24-week, Phase 2b trial for Empatic(TM) (bupropion SR/zonisamide SR), the Company's second late stage investigational combination drug for the treatment of obesity, met its primary efficacy endpoint by demonstrating statistically significantly greater weight loss for both Empatic doses compared to monotherapies and placebo.
Fewer New Yorkers are dying from the coronavirus than health experts had anticipated, a new study shows. Regional death rates have dropped from the highs seen at the start of the outbreak, partially due to a shift in the population contracting the disease toward those who are more resilient.
Professor UEYAMA Takehiko (Biosignal Research Center, Kobe University) and the inner ear research group (Kyoto Prefectural University of Medicine) have identified the cell types in the inner ear cochlea responsible for the production of superoxide (Nox3-expressing cells).
› Verified 7 days ago